Celldex Therapeutics (CLDX) Gross Profit Growth (3y) (2013)

Celldex Therapeutics (CLDX) Gross Profit Growth (3y) (2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 9.20%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 10.09%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 299.84%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 45.27%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 803.34%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 59.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 80.79%
10 Celldex Therapeutics 3.29 Bn 2.58 Bn -2.57 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 27.35%
Sep 30, 2013 95.00%
Jun 30, 2013 36.42%